USANA Health Sciences Announces Third Quarter 2008 Financial Results
SALT LAKE CITY--(BUSINESS WIRE)--
USANA Health Sciences, Inc. (NASDAQ: USNA) today announced its financial results for the third quarter, ended September 27, 2008. The company reported net sales of $107.2 million and earnings per share of $0.50.
Financial Performance
Net sales for the third quarter of 2008 increased by 0.9% to $107.2 million, compared with $106.2 million in the third quarter of the prior year. In contrast to prior quarters when sales benefited from changes in foreign currencies, net sales in the third quarter were reduced by $1.9 million, on a sequential quarterly basis, due to a stronger U.S. dollar. The total number of active Associates in the third quarter of 2008 increased by 2.2% to 184,000, compared with 180,000 in the third quarter of 2007. On a sequential quarterly basis, active Associates increased by 8.9% from 169,000.
"We were pleased to see a significant increase in the number of active Associates from the second quarter," said Dave Wentz, chief executive officer of USANA Health Sciences. "During the third quarter, at our international convention, we introduced enhancements to our already rewarding Associate Compensation Plan. The enhancements provide our independent Associates with two additional ways to earn income through their USANA home-based business."
Earnings per share from continuing operations in the third quarter of 2008 were $0.50, compared with $0.70 in the third quarter of 2007. The decrease in earnings per share was primarily due to higher overall operating expenses, including increased Associate incentives, wage-related expenses, equity-based compensation, increased depreciation expense due to significant investments in facilities that were completed in 2008, and legal fees associated with various law suits which have largely been resolved. Additionally, earnings per share in the third quarter were reduced by approximately $0.04 due to costs related to the company's response to a tender offer, which are not expected to recur in future periods.
"Over the last two years, we have made significant investments in our business to address rapid growth and to prepare USANA for anticipated future growth," said Jeff Yates, chief financial officer of USANA Health Sciences. "With time, we are confident we will gain significant leverage from these investments."
For the nine months ended September 27, 2008, net sales increased by 1.1% to $318.0 million, compared with $314.4 in the first nine months of 2007. Earnings per share were $1.58 in the first nine months of 2008, a decrease of 21.0%, compared with $2.00 in the same period of 2007.
Regional Results
North America Region
During the third quarter of 2008, net sales in North America decreased by 3.0% to $64.6 million, compared with the third quarter of the prior year. Excluding changes in foreign currency, net sales decreased by 3.8%. This decrease was mainly due to lower-than-expected sales in the U.S., where the number of active Associates declined by 3.2% on a year-over-year basis. On a sequential quarterly basis, however, active Associates increased by 7.0% in the U.S. and by 7.3% in North America.
Asia Pacific Regions
Net sales in the Asia Pacific regions, during the third quarter of 2008, increased by 7.6% to $42.6 million, compared with the third quarter of 2007. Excluding changes in foreign currency, net sales increased by 4.7% in these regions during this quarter. This growth was primarily attributable to increases of 39.1% in Hong Kong and 25.2% in Malaysia. These increases were partially offset by a 6.9% decline in Australia/New Zealand and a 7.0% decline in Singapore. Importantly, the number of active Associates in these regions increased by 5.2% on a year-over-year basis and by 11% on a sequential quarterly basis.
Outlook
The company expects net sales for the full-year 2008 to be between $432 million and $438 million and earnings per share to be between $2.22 and $2.28. Accordingly, we expect the fourth quarter of 2008 to reflect sales between $114 million and $120 million, and earnings per share to be between $0.64 and $0.70. This earnings per share estimate is based on an effective tax rate of 35.0%.
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 15, 2008 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high-quality nutritional, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements in the foregoing press release include, but are not necessarily limited to, references to the expected outcome of initiatives and promotions planned by the company, guidance given for future operating periods, and the company's belief regarding the future effect of incentive programs on the top-line and on operating costs. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
USANA Health Sciences, Inc.
Consolidated Statements of Earnings (Unaudited)
(In thousands, except per share data)
Quarter Ended
-------------------
29-Sep-07 27-Sep-08
--------- ---------
Net sales $106,181 $107,176
Cost of sales 21,960 22,228
--------- ---------
Gross profit 84,221 84,948
Operating expenses
Associate incentives 43,021 44,573
Selling, general and administrative 23,053 26,787
Research and development 864 834
--------- ---------
Earnings from operations 17,283 12,754
Other income (270) (489)
--------- ---------
Earnings from continuing operations before
income taxes 17,013 12,265
Income taxes 5,350 4,126
--------- ---------
Income from continuing operations 11,663 8,139
Loss from discontinued operations (405) -
--------- ---------
NET EARNINGS $ 11,258 $ 8,139
========= =========
Earnings per share - diluted
Continuing operations $ 0.70 $ 0.50
Discontinued operations $ (0.02) $ -
--------- ---------
Net Earnings $ 0.68 $ 0.50
========= =========
Weighted average shares outstanding - diluted 16,613 16,133
========= =========
USANA Health Sciences, Inc.
Consolidated Balance Sheets (Unaudited)
(in thousands)
As of As of
29-Dec-07 27-Sep-08
--------- ---------
ASSETS
Current Assets
Cash and cash equivalents $ 12,865 $ 13,699
Inventories 19,439 22,011
Other current assets 13,688 14,070
--------- ---------
Total current assets 45,992 49,780
Property and equipment, net 52,061 59,392
Goodwill 5,690 5,690
Other assets 5,385 6,280
--------- ---------
Total assets $109,128 $121,142
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 8,111 $ 9,384
Other current liabilities 32,074 34,875
--------- ---------
Total current liabilities 40,185 44,259
Line of credit 28,000 30,650
Other long-term liablilities 2,305 2,836
Stockholders' equity 38,638 43,397
--------- ---------
Total liabilities and stockholders' equity $109,128 $121,142
========= =========
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
29-Sep-07 27-Sep-08
---------------- ----------------
(Unaudited) (Unaudited)
Region
-------------------------------------
North America $ 66,619 62.8% $ 64,593 60.3%
Southeast Asia/Pacific 23,303 21.9% 23,265 21.7%
East Asia 12,230 11.5% 15,206 14.2%
North Asia 4,029 3.8% 4,112 3.8%
--------- ------ --------- ------
Consolidated $106,181 100.0% $107,176 100.0%
========= ====== ========= ======
Active Associates by Region (1)
As of
-----------------------------
29-Sep-07 27-Sep-08
-------------- --------------
(Unaudited) (Unaudited)
Region
----------------------------------------
North America 105,000 58.3% 103,000 56.0%
Southeast Asia/Pacific 41,000 22.8% 42,000 22.8%
East Asia 27,000 15.0% 32,000 17.4%
North Asia 7,000 3.9% 7,000 3.8%
------- ------ ------- ------
Total 180,000 100.0% 184,000 100.0%
======= ====== ======= ======
(1) Associates are independent distributors of our products who also purchase our products for their personal use. We only count as active those Associates who have purchased product from USANA at any time during the most recent three-month period, either for personal use or for resale.
Active Preferred Customers by Region (2)
As of
---------------------------
29-Sep-07 27-Sep-08
------------- -------------
(Unaudited) (Unaudited)
Region
------------------------------------------
North America 71,000 89.9% 64,000 87.7%
Southeast Asia/Pacific 6,000 7.5% 8,000 10.9%
East Asia 1,000 1.3% 1,000 1.4%
North Asia 1,000 1.3% - 0.0%
------ ------ ------ ------
Total 79,000 100.0% 73,000 100.0%
====== ====== ====== ======
(2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased product from USANA at any time during the most recent three-month period.
Source: USANA Health Sciences, Inc.
Released October 14, 2008